You are here: Industry Insights > COVID-19

News List

Prebona proves unique, long-term effect against COVID-19/SARS CoV-2 prnasia
November 06, 2020
Independent test-institutes have confirmed that Prebona Disinfect is extremely effective against the coronavirus - SARS CoV-2, COVID-19.
Magnostics is Co-Developing and Launching a Viral RNA Extraction Kit for Medium Throughput Processing of COVID-19 Samples for Detection Using RT-PCR prnewswire
November 06, 2020
A team of scientist from Saint Vincent University Hospital, National Virus Reference Laboratory, University College Dublin, and Magnostics Ltd, announced at the Science Foundation of Ireland's 2020 Science Summit the development of viral RNA extraction ..
NHS at a 'critical point' as COVID-19 cases climb pharmatimes
November 06, 2020
NHS Confederation chief executive Danny Mortimer has called for the public’s support to ensure that non-COVID services remain open by following ‘national guidance’.
Novartis, Molecular Partners to develop two DARPin Therapies for COVID-19 americanpharmaceuticalreview
November 06, 2020
Novartis and Molecular Partners announced a collaboration in the form of an option and license agreement to develop, manufacture and commercialize Molecular Partners’ anti-COVID-19 DARPin? program, consisting of two therapeutic candidates, MP0420 and MP04
Qualigen Receives Positive Pre-IND Response from FDA for COVID-19 Treatment americanpharmaceuticalreview
November 06, 2020
Qualigen Therapeutics announced receipt of written feedback to its Type B Pre-IND (Pre-Investigational New Drug application) meeting request from the U.S. Food and Drug Administration (FDA) that is in general agreement with the Company's planned ...
AIIMS find ivermectin prophylaxis reduces infection in Covid-19 patients pharmaceutical-technology
November 06, 2020
A study by All India Institutes of Medical Sciences (AIIMS)-Bhubaneswar in the Indian state of Odisha found that two doses of potential drug ivermectin prophylaxis resulted in a 73% reduction in Covid-19 infection.
Covaxin may get launched in February 2021: ICMR scientist expresspharma
November 06, 2020
The company had earlier hoped to launch it only in the second quarter of next year.
Disappointing SOLIDARITY results for remdesivir likely due to trial differences and not the drug: GlobalData expresspharma
November 06, 2020
The SOLIDARITY trial did show that large-scale international trials are possible during a pandemic with the possibility of drawing conclusions at a rapid pace, as soon as six months.
Reassess your ‘a(chǎn)lternatives’ expresspharma
November 06, 2020
Sanjaya Mariwala, Executive Chairman and Managing Director of OmniActive Health Technologies opines that it is time to give mainstream consideration to the nutraceuticals industry which is poised to grow in scale and size.
Skills and talents deficit poses biggest challenge to digital transformation in pharma expresspharma
November 06, 2020
The success of digital transformation will heavily depend on employees being on board and adapting as digital transformation process is a never-ending change.